Related Experiment Videos
Microglial activation in multiple system atrophy: a potential role for NF-kappaB/rel proteins
S C Schwarz1, T Seufferlein, S Liptay
1Department of Neurology, University of Ulm, Germany.
Neuroreport
|November 6, 1998
Summary
Nuclear factor-kappa B (NF-κB) activation in microglia is key in multiple system atrophy (MSA). Researchers found nuclear RelA p65 in MSA brain tissue, suggesting NF-κB
Area of Science:
- Neuroscience
- Immunology
- Neuropathology
Background:
- Microglial activation is a hallmark of multiple system atrophy (MSA).
- Activated microglia release proinflammatory peptides, potentially via nuclear factor-kappa B (NF-κB) activation.
- The role of NF-κB in MSA-related microglial activation requires further investigation.
Purpose of the Study:
- To investigate the nuclear presence of RelA, the 65 kDa subunit of the NF-κB/RelA family, in the striatum and brain stem of patients with MSA.
- To determine if NF-κB activation is localized within microglia in affected brain regions of MSA patients.
Main Methods:
- Immunohistochemical analysis of striatal and brain stem tissue from MSA patients and controls.
- Detection of nuclear RelA p65 immunoreactivity.
- Localization of RelA p65 within specific cell types, particularly microglia.
Main Results:
- Marked immunoreactivity for nuclear RelA p65 was observed in affected brain areas of MSA patients.
- Nuclear RelA p65 was almost exclusively localized in activated microglia.
- Nuclear translocation of RelA was not detected in the striatal tissue of control or Parkinson disease patients.
Conclusions:
- NF-κB/RelA complexes are likely involved in mediating microglial activation in multiple system atrophy.
- Targeting NF-κB signaling in microglia may represent a therapeutic strategy for MSA.
- The findings differentiate MSA neuropathology from Parkinson disease regarding microglial activation pathways.